TEHRAN (ISNA)- New studies with the help of an Iranian researcher showed that mesenchymal stem cells are safe as much as marrow cells to treat the patients suffering ischemic cardiomyopathy. Behzad Oskoueialong with other researchers at the University of Miami Miller School of Medicine conducted a study to examine the safety of transendocardial stem ...